Skip to content

Author

V. Agarwal

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Comparative Efficacy and Safety of Saroglitazar and Dapagliflozin on Hepatic Steatosis and Glycemic Control in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A 25‐Week Prospective Multicenter Comparative Cohort Study

ABSTRACT Introduction Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease globally, driven by rising obesity and type 2 diabetes mellitus (T2DM). Existing medications provide minimal fibrosis regression, highlighting the need for comparative evidence on agents...

Mukulesh Gupta, K. Chandra, R. Awasthi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.